Feasibility and acceptability of a timeline follow-back method to assess opioid use, non-fatal overdose, and substance use disorder treatment.
Feasibility and acceptability of a timeline follow-back method to assess opioid use, non-fatal overdose, and substance use disorder treatment.
复制标题
评估阿片类药物使用、非致命过量和物质使用障碍治疗的时间线随访方法的可行性和可接受性。
DOI：
10.1016/j.addbeh.2023.107873
复制
发表时间：
2024
影响因子：
4.4
通讯作者：
Walley,AlexanderY
中科院分区：
文献类型：
--
作者：
McCann,NicoleC;McMahan,VanessaM;Smith,Rachel;Majeski,Adam;Johns,SarahL;Kosakowski,Sarah;Wolfe,Shae;Brennan,Sarah;Robinson,Mackenzie;Coffin,PhillipO;Walley,AlexanderY
背景非致死性阿片类药物过量报告不足，目前尚无公认的可行的非致死性阿片类药物过量自我报告研究措施。时间轴随访（TLFB）基于问卷的调查评估自我报告的风险行为。我们评估了一项新的TLFB研究措施的可行性和可接受性，用于阿片类药物使用，非致命性阿片类药物过量，以及阿片类药物过量幸存者中的物质使用障碍治疗。方法对于阿片类药物过量幸存者中的重复剂量行为干预减少阿片类药物过量试验（REBOOT）研究，我们开发了TLFB问卷，以评估每日非处方阿片类药物使用，阿片类药物过量，设施停留，阿片类药物使用障碍的药物/行为治疗，以及过去120天内的COVID-19病史。在16个月的研究参与期内，工作人员评估员在每4个月一次的访视中管理TLFB。为了衡量可行性，我们估计TLFB完成时间使用电子时间戳工具。为了衡量可接受性，我们对103名完成REBOOT.ResultsAmong的参与者进行了满意度调查，其中174名参与者从2021年1月至2023年1月进行了525 TLFB评估，510项评估中报告了阿片类药物使用，331项评估中报告了阿片类药物使用障碍（MOUD），107项评估中报告了≥ 1次用药过量。所有受试者接受的切片的中位TLFB完成时间为11（IQR：6-17）分钟;向报告过量的受试者提供详细的过量问题需要额外3（IQR：2-6）分钟。报告≥ 1次用药过量和MOUD使用与TLFB完成时间延长显著相关。88%的参与者报告说，TLFB是非常/有点acceptable.ConclusionsAmong阿片类药物过量幸存者，REBOOT TLFB是一个可行的和可接受的研究措施，与其他TLFB评估物质使用的完成时间相似。
BackgroundNon-fatal overdoses are underreported and there is no accepted and feasible self-report research measure of non-fatal opioid overdose. Timeline follow-back (TLFB) calendar-based questionnaires assess self-reported risk behaviors. We assessed feasibility and acceptability of a new TLFB research measure for opioid use, non-fatal opioid overdose, and substance use disorder treatment among opioid overdose survivors.MethodsFor the Repeated-dose Behavioral Intervention to Reduce Opioid Overdose Trial (REBOOT) study among opioid overdose survivors, we developed a TLFB questionnaire to assess daily non-prescribed opioid use, opioid overdose, facility stays, medications/behavioral treatment for opioid use disorder, and COVID-19 history during the previous 120 days. Staff assessors administered TLFB at four-monthly visits over the 16-month study participation period. To measure feasibility, we estimated TLFB completion time using an electronic timestamp tool. To measure acceptability, we administered a satisfaction survey to 103 participants who completed REBOOT.ResultsAmong 525 TLFB assessments conducted in 174 participants from January 2021-January 2023, opioid use was reported in 510 assessments, medication for opioid use disorder (MOUD) in 331 assessments, and ≥ 1 overdose in 107 assessments. Median TLFB completion time was 11 (IQR: 6–17) minutes for sections administered to all participants; detailed overdose questions administered to those reporting overdose took an additional 3 (IQR: 2–6) minutes. Report of ≥ 1 overdose and MOUD use were significantly associated with increased TLFB completion time. 88 % of participants reported that TLFB was very/somewhat acceptable.ConclusionsAmong opioid overdose survivors, REBOOT TLFB was a feasible and acceptable research measure, with similar completion time as other TLFB assessments of substance use.